Twist Bioscience, Distributed Bio Partner

News   Oct 13, 2016

 
Twist Bioscience, Distributed Bio Partner
 
 
 

RELATED ARTICLES

Meningococcal Vaccine Could Protect Against 91% of Targeted Bacterial Strains

News

“We are very pleased to see that it looks like the vaccine has the potential to cover most of the strains of meningococcal Group B bacteria currently circulating in the U.S.,” said lead study author Gowrisankar Rajam, Ph.D.

READ MORE

AIDS Vaccine Design: New Data Offers Important Insight

News

New data published in Immunity further illuminate how some human beings generate powerful, HIV-blocking antibodies. The results offer important insight into a potential AIDS vaccine design.

READ MORE

New Target for ‘Triple-negative’ Breast Cancer Discovered

News

University of Virginia researchers are working to study this variability and find an end-around method to stop triple-negative breast cancer, by seeking out unknown or little-understood routes toward shutting down uncoordinated growth.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE